Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 21, 2023; 29(15): 2336-2348
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2336
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2336
Table 3 Outcomes of symptoms in the four groups
| Symptoms | Group A | Group B | χ2 | Pvalue | Group C | Group D | χ2 | Pvalue |
| Ascites within 1 wk | / | / | / | 198 (198/217, 91.24%) | 161 (161/172, 93.60%) | 0.327 | ||
| Hemorrhage within 1 wk | 0 | 0 | 0 | / | / | / | ||
| Primary unassisted patency rate | 0.8641 | 0.8724 | 4.486 | 0.257 | 0.8531 | 0.8429 | 4.529 | 0.248 |
| Hepatic function compromise | 43 (43/479, 8.97%) | 96 (96/412, 23.30%) | 11.352 | 0.005 | 27 (27/217, 12.44%) | 63 (63/172, 36.62%) | 13.758 | 0.002 |
| Recurrence of hemorrhage | 56 (56/479, 11.69%) | 47 (47/412, 11.40%) | 7.062 | 0.374 | / | / | / | / |
| Stent dysfunction | 27 (27/479, 5.63%) | 21 (21/412, 5.09%) | 6.834 | 0.358 | / | / | / | / |
| Non-stent dysfunction | 29 (29/479, 6.05%) | 26 (26/412, 6.31%) | 6.486 | 0.362 | / | / | / | / |
| Recurrence of ascites | / | / | / | / | 89 (89/217, 41.01%) | 126 (126/172,73.25%) | 14.493 | 0.006 |
| Stent dysfunction | / | / | / | / | 13 (13/217, 5.99%) | 9 (9/172, 5.23%) | 4.574 | 0.375 |
| Non-stent dysfunction | / | / | / | / | 76 (76/217, 35.02%) | 117 (117/172, 68.02%) | 13.356 | 0.006 |
- Citation: Luo SH, Zhou MM, Cai MJ, Han SL, Zhang XQ, Chu JG. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications. World J Gastroenterol 2023; 29(15): 2336-2348
- URL: https://www.wjgnet.com/1007-9327/full/v29/i15/2336.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i15.2336